Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000421335 | SCV000522008 | likely benign | not specified | 2018-01-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000726639 | SCV000701889 | uncertain significance | not provided | 2016-10-03 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001400969 | SCV001602780 | likely benign | X-linked Emery-Dreifuss muscular dystrophy | 2023-12-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002411328 | SCV002715986 | likely benign | Cardiovascular phenotype | 2020-02-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001828412 | SCV002084676 | likely benign | Emery-Dreifuss muscular dystrophy | 2020-04-11 | no assertion criteria provided | clinical testing |